Clinical Trial: A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults

U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07717775) titled 'A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults' on July 16.

Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-234, AD-2341, AD-2342 in healthy subjects.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Gastritis

Intervention: DRUG: AD-234

AD-234 tablet administered orally

DRUG: AD-2341

AD-2341 tablet administered orally

DRUG: AD-2342

AD-2342 tablet administered orally

Recruitment Status: NOT_YET_...